Post by Genentech

Name: The FDA granted priority review to our treatment for primary membranous nephropathy (pMN). pMN is
Uploaded: 2026-07-15T15:00:01.851Z
Channel: Genentech
Description: The FDA granted priority review to our treatment for primary membranous nephropathy (pMN). pMN is a debilitating, chronic disease where the body’s immune system attacks the kidney’s filtering units.

947,722 followers

The FDA granted priority review to our treatment for primary membranous nephropathy (pMN). pMN is a debilitating, chronic disease where the body’s immune system attacks the kidney’s filtering units. Our treatment could offer a dedicated option to help prevent progression to kidney failure, addressing a critical unmet need for pMN patients. If approved, it would be the first FDA-approved therapy specifically indicated to treat this disease. Learn more: http://spr.ly/6046BEXlTC

Video Content